NUROKIND NEXT (Benfothiamine, Mecobalamin, Alpha Lipoic Acid, Pyridoxine, Folic acid, Biotin and Chromium)

Nurokind-Next Capsule contains a combination of ingredients, including Benfothiamine, Mecobalamin, Alpha Lipoic Acid, Pyridoxine, Folic Acid, Biotin, and Chromium. Each component plays a critical role in supporting health, particularly in conditions related to diabetes. Benfotiamine is known to enhance the activity of transketolase, which helps to diminish the accumulation of harmful glucose byproducts. This reduction may contribute to the prevention of advanced glycation end products (AGEs) that are associated with various complications of diabetes, including damage to vision known as diabetic retinopathy. Both Benfotiamine and Alpha Lipoic Acid are recognized as foundational elements in managing diabetic neuropathy. Biotin is beneficial for improving the metabolism of glucose and increasing insulin sensitivity in muscle tissue. Chromium, another key ingredient, has demonstrated effectiveness in lowering blood sugar levels and managing HbA1c levels in individuals diagnosed with type 2 diabetes. Due to these properties, Nurokind-Next Capsule is indicated for individuals suffering from diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, cardiovascular diseases, and alcoholic neuropathy. Regular use, as directed by a healthcare professional, may aid in the management of these diabetes-related conditions. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.